Metformin use may associate with a good prognosis in lung cancer patients with type 2 diabetes but the effect was modest. However, it could achieve benefits in a selective sub-group of lung cancer patients especially in SCLC patients from Asian. Further studies are warranted to confirm this efficacy.

No abstract

The polymeric architecture greatly influences the properties of polymer drug carriers.

Stimuli responsive functional polymer isomers performed variously serving as drug carriers for cancer therapy.